These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8395233)

  • 21. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways.
    D'Addario M; Libermann TA; Xu J; Ahmad A; Menezes J
    J Mol Biol; 2001 May; 308(3):501-14. PubMed ID: 11327783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.
    Scala G; Morrone G; Tamburrini M; Alfinito F; Pastore CI; D'Alessio G; Venuta S
    J Immunol; 1987 Apr; 138(8):2527-34. PubMed ID: 2435800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of IL-6 on proliferation and IG production of human EBV-transformed cell lines in serum free culture media.
    Jochems GJ; Jordens R; van Lier RA; Zeijlemaker WP
    Dev Biol Stand; 1990; 71():57-63. PubMed ID: 2169441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line.
    Vandenabeele P; Jayaram B; Devos R; Shaw A; Fiers W
    Eur J Immunol; 1988 Jul; 18(7):1027-31. PubMed ID: 2841138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.
    Hellebrand E; Mautner J; Reisbach G; Nimmerjahn F; Hallek M; Mocikat R; Hammerschmidt W
    Gene Ther; 2006 Jan; 13(2):150-62. PubMed ID: 16136164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.
    Beatty PR; Krams SM; Martinez OM
    J Immunol; 1997 May; 158(9):4045-51. PubMed ID: 9126962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
    Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interleukin-1-like factor from human B-lymphocytes transformed by the Epstein-Barr virus].
    Kotov AIu; Simbirtsev AS; Perumov ND; Ketlinskiĭ SA
    Tsitologiia; 1989 Feb; 31(2):226-33. PubMed ID: 2544049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EBV transformation overrides gene expression patterns of B cell differentiation stages.
    Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
    Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
    Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells.
    Tóth FD; Aboagye-Mathiesen G; Nemes J; Liu X; Andirkó I; Hager H; Zdravkovic M; Szabó J; Kiss J; Aranyosi J; Ebbesen P
    Virology; 1997 Mar; 229(2):400-14. PubMed ID: 9126252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
    Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
    J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals.
    Palmer EM; van Seventer GA
    J Immunol; 1997 Mar; 158(6):2654-62. PubMed ID: 9058798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
    Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
    Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.
    Buck J; Hämmerling U; Hoffmann MK; Levi E; Welte K
    J Immunol; 1987 May; 138(9):2923-8. PubMed ID: 3033079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
    Yajima M; Kanda T; Takada K
    J Virol; 2005 Apr; 79(7):4298-307. PubMed ID: 15767430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
    Woodford NL; Call DR; Remick DG; Rochford R
    Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
    Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.